Sinphar Pharmaceutical Market Cap

Sinphar Pharmaceutical has a market cap or net worth of 5.91 billion as of June 6, 2025. Its market cap has decreased by -4.46% in one year.

Market Cap

5.91B

Enterprise Value

6.92B

Revenue

3.18B

Ranking

n/a

PE Ratio

19.29

Stock Price

32.60

Market Cap Chart

Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 5.91B, an increase of 424.72%. That is a compound annual growth rate of 7.78%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	5.91B	4.49%
Dec 31, 2024	5.65B	-0.75%
Dec 29, 2023	5.69B	2.41%
Dec 30, 2022	5.56B	14.71%
Dec 30, 2021	4.85B	-6.62%
Dec 31, 2020	5.19B	59.54%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	176.01B
Caliway Biopharmaceuticals	141.78B
Bora Pharmaceuticals Co., LTD.	85.98B
Lotus Pharmaceutical	62.00B
Polaris Group	31.40B
Lumosa Therapeutics	29.21B
Center Laboratories	28.89B
Oneness Biotech	27.45B

Market Cap Rankings